Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daoud Meerzaman

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
Plos One|September 24, 2015
Transcriptome Profiling of Pediatric Core Binding Factor AMLChih-Hao Hsu, Cu Nguyen, Chunhua Yan, et al.
Nature Communications|May 3, 2025
The ESCRT protein CHMP5 promotes T cell leukemia by enabling BRD4-p300-dependent transcriptionKatharine Umphred-Wilson, Shashikala Ratnayake, Qianzi Tang, et al.
Biorxiv : the Preprint Server for Biology|January 18, 2024
<i>Timp2</i> loss-of-function mutation and TIMP2 treatment in murine model of NSCLC: modulation of immunosuppression and oncogenic signalingDavid Peeney, Sarvesh Kumar, Tej Pratap Singh, et al.
Frontiers in Oncology|August 28, 2023
Glioblastoma survival is associated with distinct proteomic alteration signatures post chemoirradiation in a large-scale proteomic panelAndra Valentina Krauze, Michael Sierk, Trinh Nguyen, et al.
Translational Oncology|February 4, 2025
Timp2 loss-of-function mutation and TIMP2 treatment in a murine model of NSCLC: Modulation of immunosuppression and oncogenic signalingDavid Peeney, Sarvesh Kumar, Tej Pratap Singh, et al.
Nature Communications|September 24, 2021
A comprehensive map of alternative polyadenylation in African American and European American lung cancer patientsAdriana Zingone, Sanju Sinha, Michael Ante, et al.
Research Square|March 27, 2026
Temporal Integration of Serum Proteomics, Metabolomics and MRI Tumor Volumetrics via Deep Learning Identifies Systemic Mediators of Glioblastoma Response to ChemoradiotherapyAndra Krauze, Trinh Nguyen, Michael Sierk, et al.
Frontiers in Oncology|March 28, 2024
Corrigendum: Glioblastoma survival is associated with distinct proteomic alteration signatures post chemoirradiation in a large-scale proteomic panelAndra Valentina Krauze, Michael Sierk, Trinh Nguyen, et al.
The Journal of Biological Chemistry|December 5, 2022
Flotillin-2 regulates epidermal growth factor receptor activation, degradation by Cbl-mediated ubiquitination, and cancer growthDavid J Wisniewski, Mariya S Liyasova, Soumya Korrapati, et al.
Cancer Research|March 15, 2024
NCI Cancer Research Data Commons: Lessons Learned and Future StateErika Kim, Tanja Davidsen, Brandi N Davis-Dusenbery, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
Plos One|September 24, 2015
Transcriptome Profiling of Pediatric Core Binding Factor AMLChih-Hao Hsu, Cu Nguyen, Chunhua Yan, et al.
Nature Communications|May 3, 2025
The ESCRT protein CHMP5 promotes T cell leukemia by enabling BRD4-p300-dependent transcriptionKatharine Umphred-Wilson, Shashikala Ratnayake, Qianzi Tang, et al.
Biorxiv : the Preprint Server for Biology|January 18, 2024
<i>Timp2</i> loss-of-function mutation and TIMP2 treatment in murine model of NSCLC: modulation of immunosuppression and oncogenic signalingDavid Peeney, Sarvesh Kumar, Tej Pratap Singh, et al.
Frontiers in Oncology|August 28, 2023
Glioblastoma survival is associated with distinct proteomic alteration signatures post chemoirradiation in a large-scale proteomic panelAndra Valentina Krauze, Michael Sierk, Trinh Nguyen, et al.
Translational Oncology|February 4, 2025
Timp2 loss-of-function mutation and TIMP2 treatment in a murine model of NSCLC: Modulation of immunosuppression and oncogenic signalingDavid Peeney, Sarvesh Kumar, Tej Pratap Singh, et al.
Nature Communications|September 24, 2021
A comprehensive map of alternative polyadenylation in African American and European American lung cancer patientsAdriana Zingone, Sanju Sinha, Michael Ante, et al.
Research Square|March 27, 2026
Temporal Integration of Serum Proteomics, Metabolomics and MRI Tumor Volumetrics via Deep Learning Identifies Systemic Mediators of Glioblastoma Response to ChemoradiotherapyAndra Krauze, Trinh Nguyen, Michael Sierk, et al.
Frontiers in Oncology|March 28, 2024
Corrigendum: Glioblastoma survival is associated with distinct proteomic alteration signatures post chemoirradiation in a large-scale proteomic panelAndra Valentina Krauze, Michael Sierk, Trinh Nguyen, et al.
The Journal of Biological Chemistry|December 5, 2022
Flotillin-2 regulates epidermal growth factor receptor activation, degradation by Cbl-mediated ubiquitination, and cancer growthDavid J Wisniewski, Mariya S Liyasova, Soumya Korrapati, et al.
Cancer Research|March 15, 2024
NCI Cancer Research Data Commons: Lessons Learned and Future StateErika Kim, Tanja Davidsen, Brandi N Davis-Dusenbery, et al.
Pageof 9